Umecrine Cognition
Pre-clinicalUmecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Founded
2015
Focus
Small Molecules
About
Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Funding History
2Total raised: $11.2M
Series A$10MIndustrifondenMar 15, 2021
Grant$1.2MSwedish Innovation Agency (Vinnova)Sep 15, 2020
Company Info
TypePrivate
Founded2015
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile